Asensus Surgical Inc [AMEX: ASXC] loss -0.64% or -0.01 points to close at $0.32 with a heavy trading volume of 3277820 shares.
The daily chart for ASXC points out that the company has recorded 13.75% gains over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 2.52M shares, ASXC reached to a volume of 3277820 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Asensus Surgical Inc [ASXC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ASXC shares is $0.35 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ASXC stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Asensus Surgical Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 16, 2023. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on September 08, 2022, representing the official price target for Asensus Surgical Inc stock. Previously, the target price had yet another raise to $4, while H.C. Wainwright analysts kept a Buy rating on ASXC stock.
The Average True Range (ATR) for Asensus Surgical Inc is set at 0.01, with the Price to Sales ratio for ASXC stock in the period of the last 12 months amounting to 10.13. The Price to Book ratio for the last quarter was 6.77, with the Price to Cash per share for the same quarter was set at 0.03.
Trading performance analysis for ASXC stock
Asensus Surgical Inc [ASXC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.91. With this latest performance, ASXC shares gained by 29.68% in over the last four-week period, additionally plugging by 13.75% over the last 6 months – not to mention a drop of -37.65% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASXC stock in for the last two-week period is set at 69.18, with the RSI for the last a single of trading hit 72.00, and the three-weeks RSI is set at 65.47 for Asensus Surgical Inc [ASXC]. The present Moving Average for the last 50 days of trading for this stock 0.2645, while it was recorded at 0.3285 for the last single week of trading, and 0.2726 for the last 200 days.
Asensus Surgical Inc [ASXC]: A deeper dive into fundamental analysis
Asensus Surgical Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.69 and a Current Ratio set at 1.00.
An analysis of Institutional ownership at Asensus Surgical Inc [ASXC]
The top three institutional holders of ASXC stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in ASXC stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in ASXC stock with ownership which is approximately 5.8386%.
